Lv45
680 积分 2022-05-31 加入
Tumor-draining lymph nodes: At the crossroads of metastasis and immunity
7天前
已完结
Non-depleting anti-CD19 B cell inhibition
16天前
已完结
Factors predicting hyperprogression in patients with advanced ovarian cancer receiving anti-programmed cell death 1-therapy
19天前
已完结
Opportunities and limitations of B cell depletion approaches in SLE
22天前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
22天前
已完结
Effect Of Crossover-Surgery At The Subsequent Relapse On The Survival Of Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Prespecified And Post-Hoc Analyses Of The SOC-1 Randomized Phase 3 Trial
28天前
已关闭
Isolated lymph node recurrence in epithelial ovarian cancer – management and outcome
1个月前
已完结
Chemotherapy With Or Without Pembrolizumab Followed By Maintenance With Olaparib Or Placebo For First-Line Treatment Of Advanced BRCA Non-Mutated Epithelial Ovarian Cancer: Results From The Randomized Phase 3 ENGOT-OV43/GOG-3036/KEYLYNK-001 Study
1个月前
已关闭
A guide to artificial intelligence for cancer researchers
1个月前
已完结
Artificial intelligence in drug development
1个月前
已完结
皖公网安备34019202002308
